Development of Multivalent mRNA Vaccine Candidates for Seasonal or Pandemic Influenza

0
22
Utilizing multiple influenza antigens, scientists demonstrated the suitability of the mRNA therapeutic platform for such applications.
[NPJ Vaccines]
Full Article